PK and PD Crossover Study After Single Dose, Intravenous Administration of Two Epoetin Alfa, Human Recombinant Epoetin and Eprex, in Healthy Subjects.
Clinical trial NCT01685333 · COMPLETED
Trial details
- NCT number
- NCT01685333
- Sponsor
- Azidus Brasil
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2013-02-28
- Primary completion
- 2013-10-31
- Enrollment
- 28
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.